Please find the session links next to their corresponding agenda item.
Wednesday, November 10
11:00 AM
FDLI Welcome and Announcements
Khara L. Minter, Assistant Director, Training Programs, FDLI
Enter this session: https://fdli.zoom.us/j/89058701325
11:05 AM– 12:05 PM
Biologics and Biosimilars
Christopher Gallo, Associate, Axinn, Veltrop & Harkrider LLP
Enter this session: https://fdli.zoom.us/j/89058701325
12:05 – 1:05 PM
Regulation of Over-the-Counter (OTC) Drugs
Deborah L. Livornese, Director, Hyman, Phelps & McNamara, PC
Enter this session: https://fdli.zoom.us/j/87361468021
1:05 – 1:15 PM
Break
1:15 – 2:15 PM
Regulation of Drug Manufacturing
Peter V. Lindsay, Partner, Paul Hastings
Enter this session: https://fdli.zoom.us/j/89516395022
2:30 – 3:30 PM
Regulation of Drug Marketing
Heather Banuelos, Counsel, King & Spalding LLP
Gillian M. Russell, Counsel, King & Spalding LLP
Enter this session: https://fdli.zoom.us/j/85301768056
3:30 – 3:45 PM
Break
3:45 – 5:00 PM
Violations and Enforcement
Tiffany Humphries, Senior Associate, BakerMcKenzie
Enter this session: https://fdli.zoom.us/j/84201776704